Rodon, P., Hulin, C., Pegourie, B., Tiab, M., Anglaret, B., Benboubker, L., Jardel, H., Decaux, O., Kolb, B., Roussel, M., Garderet, L., Leleu, X., Fitoussi, O., Chaleteix, C., Casassus, P., Lenain, P., Royer, B., Banos, A., Benramdane, R., Cony-Makhoul, P., Dib, M., Fontan, J., Stoppa, A.-M., Traullé, C., Vilque, J.-P., Pétillon, M.-O., Mathiot, C., Dejoie, T., Avet-Loiseau, H. and Moreau, P. (2015) “Phase II study of bendamustine, bortezomib and dexamethasone as second-line treatment for elderly patients with multiple myeloma: the Intergroupe Francophone du Myelome 2009-01 trial”, Haematologica. Pavia, Italy, 100(2), pp. e56-e59. doi: 10.3324/haematol.2014.110890.